Physician profile
Anand Singla
NPI 1487965463
$24,710.30
in general payments reported to CMS, 2019-2025
12 companies · $879 in 2025
The $879 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $968 · 2020: $3,927 · 2021: $4,646 · 2022: $12K · 2023: $1,573 · 2024: $1,047 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,242 · Travel and Lodging: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.99 |
| Travel and Lodging | $1,257.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,923.64 | 2019-2025 | Apollo Esg Nxt System, Axios, General - Therapies |
| Covidien LP | $3,629.55 | 2019-2020 | |
| Olympus Corporation of The Americas | $843.06 | 2023-2024 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Novartis Pharmaceuticals Corporation | $444.40 | 2023-2024 | |
| Fujifilm Healthcare Americas Corporation | $316.64 | 2024 | Fujifilm |
| 3-D Matrix, INC. | $164.92 | 2024 | |
| Olympus America INC. | $154.45 | 2021-2022 | |
| Abbvie INC. | $122.96 | 2023 | Rinvoq |
| Omega Medical Imaging, LLC | $49.28 | 2024 | |
| Erbe USA INC | $30.00 | 2024 | Vio 3 |
| Creo Medical INC. | $19.18 | 2024 | Speedboat Ultraslim (Sb1l) |
| Apollo Endosurgery US INC | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.